---
title: "OneMedNet Faces Nasdaq Non-Compliance Over Minimum Bid Price"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283406189.md"
description: "OneMedNet (ONMD) has received a notice from Nasdaq for non-compliance with the $1.00 minimum bid price requirement, as its stock traded below this threshold for 30 consecutive business days. The company has 180 days to raise its share price to at least $1.00 for ten consecutive trading days, with a possible extension. OneMedNet may consider options like a reverse stock split to regain compliance, but failure to meet Nasdaq requirements could lead to delisting, impacting liquidity and capital access. The company operates in healthcare and medical data technology, with a market cap of $46.04M."
datetime: "2026-04-20T21:56:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283406189.md)
  - [en](https://longbridge.com/en/news/283406189.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283406189.md)
---

# OneMedNet Faces Nasdaq Non-Compliance Over Minimum Bid Price

### Claim 30% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

OneMedNet ( (ONMD) ) has issued an announcement.

On April 14, 2026, OneMedNet disclosed that it had received a notice from Nasdaq staff stating that the company is no longer in compliance with the exchange’s $1.00 minimum bid price requirement, after its common stock traded below that threshold for 30 consecutive business days. Under Nasdaq rules, OneMedNet now has 180 calendar days, until October 12, 2026, to lift its share price to at least $1.00 for ten straight trading days, and could receive a further 180-day extension if it meets other listing standards and commits to a remedial plan.

The company said it will monitor its share price and may pursue options such as a reverse stock split to regain compliance, but cautioned that there is no guarantee it will succeed, and failure to meet the bid price or other Nasdaq requirements could lead to the stock being delisted from the Nasdaq Capital Market, potentially reducing liquidity and access to capital for shareholders and the business.

**More about OneMedNet**

OneMedNet Corporation operates in the healthcare and medical data technology sector, focusing on solutions that leverage clinical data and imaging for research, diagnostics, or related healthcare applications. The company’s shares are listed on the Nasdaq Capital Market, giving it access to public equity investors and subjecting it to Nasdaq’s continued listing requirements.

**Average Trading Volume:** 4,119,581

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $46.04M

### Related Stocks

- [ONMD.US](https://longbridge.com/en/quote/ONMD.US.md)
- [ONMDW.US](https://longbridge.com/en/quote/ONMDW.US.md)

## Related News & Research

- [Aspire Biopharma Announces 1-for-30 Reverse Stock Split](https://longbridge.com/en/news/286469924.md)
- [LifeSci Capital Sticks to Their Buy Rating for MoonLake Immunotherapeutics (MLTX)](https://longbridge.com/en/news/286649191.md)
- [How Investors May Respond To American Healthcare REIT (AHR) Cutting 2026 Profit Outlook After Q1 Results](https://longbridge.com/en/news/286866277.md)
- [Ventas Expands ATM Program to Bolster Capital Flexibility](https://longbridge.com/en/news/286623366.md)
- [UnitedHealth Group Incorporated $UNH Holdings Boosted by GSA Capital Partners LLP](https://longbridge.com/en/news/286878927.md)